Forty-nine Wisconsin technology companies will share a total of $13.1 million in federal grants through a new program, the Affordable Care Act.

Under the program, the Qualified Therapeutic Discovery Project provides tax credits and grants to small companies that "show significant potential to produce new and cost-saving therapies, support U.S. jobs and increase U.S. competitiveness," according to a statement on the website of the Internal Revenue Service, which issued the certifications after an evaluation by the U.S. Department of Health and Human Services.

The recipients include these companies in the Madison area:

  • AhR Pharmaceuticals: $4,433
  • BioSentinel Pharmaceuticals: $244,479
  • CDI Bioscience: $244,479
  • Cellectar: $244,479
  • Cellular Dynamics International: $977,914
  • Compact Particle Acceleration Corp.: $244,479
  • ConjuGon: $244,479
  • Deltanoid Pharmaceuticals: $677,379
  • EraGen Biosciences: $244,479
  • Eso-Technologies: $244,479
  • Exact Sciences Corp.: $244,479
  • Flex Biomedical: $244,479
  • FluGen: $450,130
  • InvivoSciences: $244,479
  • ioGenetics: $244,479
  • Mithridion: $244,479
  • NanoMedex Pharmaceuticals: $244,479
  • NanoOncology: $244,479
  • Nerites Corp.: $244,479
  • NeurEndo Pharma: $244,479
  • NeuWave Medical: $244,479
  • NorthStar Medical Radioisotopes: $244,479
  • Perscitus Biosciences: $244,479
  • Pharming Healthcare: $488,958
  • ProCertus BioPharm: $244,479
  • Quintessence Biosciences: $244,479
  • Ratio: $150,402
  • Scarab Genomics: $244,479
  • Spectrocon International: $244,479
  • Stablebody Technologies: $232,436
  • Stemina Biomarker Discovery: $70,819
  • Stratatech Corp.: $244,479
  • Waypoint Health Innovators: $166,473
  • Inviragen, whose headquarters is listed as Fort Collins, Colo., and Madison is getting $488,958.
  • Also, Echometrix was issued tax credits of $133,131 through the program.
0
0
0
0
0